RheumNow Live 2024

+ Include: 42 videos, size: 35.05 GB

+ Target Audience: rheumatologists and clinical immunologists

+ Information:

1. Overview

The RheumNow Live 2024 course provides a comprehensive clinical update on the diagnosis and management of complex rheumatic and autoimmune diseases. The program features expert-led sessions on the latest therapeutic advancements, clinical guidelines, and emerging biomarkers across core rheumatology domains, including SLE, rheumatoid arthritis, psoriatic disease, and spondyloarthritis.

Course Date: 2024

2. Learning Objectives

• Evaluate the biology of lupus flares and implement emerging biomarkers for the accurate diagnosis and treatment of SLE.

• Apply updated ACR, EULAR, and GRAPPA guidelines for the selection of systemic therapies in psoriatic disease and spondyloarthritis.

• Assess the clinical efficacy, safety concerns, and expanding applications of JAK inhibitors within the rheumatology treatment paradigm.

• Formulate proactive clinical strategies for the prevention and nutritional management of rheumatoid arthritis.

• Implement evidence-based approaches for managing ANCA-associated vasculitis, addressing pregnancy complexities, and mitigating malignancy risks in myositis.

3. Target Audience

Best for rheumatologists and clinical immunologists who want updates on SLE, rheumatoid arthritis, JAK inhibitors, and spondyloarthritis.

4. Topics

1. Adjourn
2. Biology and Rx of Lupus Flares
3. BONUS STEP
4. Choosing Systemic Therapies for Psoriatic Disease
5. CurrentFuture Biomarkers in SLE
6. Enthesitis in Spondyloarthritis
7. EULAR vs ACR vs GRAPPA Guidelines
8. Expanding Use of JAK Inhibitors in Dermatology
9. Future Therapy of Axial Spondyloarthritis
10. Gender Differences in PsA Outcomes Management
11. GPA Managment in 2024
12. JAK Faculty QA
13. JAK Inhibition in Spondyloarthritis
14. JAK Inhibitors in the Paradigm
15. Lessons from Cardio-Rheumatology Clinic
16. Mastering SLE
17. Nonradiographic Axial Spondyloarthritis
18. Nutrition in RA
19. Prevention of RA
20. Psoriatic Arthritis – Hot Topics
21. Psoriatic Faculty QA
22. RA Faculty Panel QA
23. Rethinking Pre-Clinical Disease in Lupus
24. Rheumatoid Arthritis Success in Rheumatoid Arthritis
25. Safety Concerns with JAK Inhibitors
26. SLE Faculty Panel QA
27. Spondyloarthritis Faculty Panel QA
28. Spondyloarthritis Spectrum
29. STEP Appreciative Rheumatology Building On The Positive
30. STEP Dead Words Eulogy
31. STEP Ethics in Rheumatology
32. STEP Immunosenescence in RA
33. STEP Lest we forget the flare
34. STEP Myositis Malignancy Risk Screening
35. STEP Myths Mistakes on ANCA-Associated Vasculitis
36. Treat to Target in Vasculitis
37. Vasculitis Faculty Panel QA
38. Vasculitis Mavens
39. Vasculitis Pregnancy
40. VIRTUAL SHOWCASE – Clinical Relevance of High Rheumatoid Factor in Patients With Rheumatoid Arthritis Non-CME
41. VIRTUAL SHOWCASE – DEFY Expectations Challenge Treatment Goals in Your Adult TNFi-IR Patients with Active Psoriatic A…
42. Welcome Introductions